Post-earnings recap
Reported
Thu, Oct 17, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported an EPS of $1.02, slightly missing expectations. Despite this, the stock saw a modest increase of 0.26%, indicating that investors may have been relieved by the overall performance or are optimistic about future prospects. The lack of revenue data and management commentary leaves some uncertainty about the company's direction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.02 | N/A | -2.21% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.